Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study.

Plass D, Mangen MJ, Kraemer A, Pinheiro P, Gilsdorf A, Krause G, Gibbons CL, VAN Lier A, McDONALD SA, Brooke RJ, Kramarz P, Cassini A, Kretzschmar ME.

Epidemiol Infect. 2014 Oct;142(10):2024-35. doi: 10.1017/S0950268813003312. Epub 2014 Jan 2.

PMID:
24480146
2.

The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands.

McDonald SA, van Lier A, Plass D, Kretzschmar ME.

BMC Public Health. 2012 Dec 5;12:1046. doi: 10.1186/1471-2458-12-1046.

3.

Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem.

García-Fulgueiras A, García-Pina R, Morant C, de Larrea-Baz NF, Alvarez E.

J Viral Hepat. 2011 Oct;18(10):e453-60. doi: 10.1111/j.1365-2893.2011.01467.x. Epub 2011 Jun 1.

PMID:
21914063
4.

Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011.

Colzani E, McDonald SA, Carrillo-Santisteve P, Busana MC, Lopalco P, Cassini A.

Vaccine. 2014 Apr 1;32(16):1814-9. doi: 10.1016/j.vaccine.2014.01.094. Epub 2014 Feb 13.

5.

Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.

Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, Haller S, Harder T, Klingeberg A, Sixtensson M, Velasco E, Weiß B, Kramarz P, Monnet DL, Kretzschmar ME, Suetens C.

PLoS Med. 2016 Oct 18;13(10):e1002150. doi: 10.1371/journal.pmed.1002150. eCollection 2016 Oct.

6.

The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases.

Mangen MJ, Plass D, Havelaar AH, Gibbons CL, Cassini A, Mühlberger N, van Lier A, Haagsma JA, Brooke RJ, Lai T, de Waure C, Kramarz P, Kretzschmar ME; BCoDE consortium.

PLoS One. 2013 Nov 20;8(11):e79740. doi: 10.1371/journal.pone.0079740. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/caf33818-3453-4e30-b307-7526427b09b7.

7.

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS.

Int J Epidemiol. 2005 Dec;34(6):1329-39. Epub 2005 Oct 25.

PMID:
16249217
8.

[Estimation on disease burden related to hepatitis B virus infection in Shandong province of China].

Qi WT, Sun JD, Xu AQ, Zhang L, Li RP, Ma JX, Guo XL, Fan QY, Yang H.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Jul;30(7):679-83. Chinese.

PMID:
19957589
9.

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.

van Lier A, McDonald SA, Bouwknegt M; EPI group, Kretzschmar ME, Havelaar AH, Mangen MJ, Wallinga J, de Melker HE.

PLoS One. 2016 Apr 20;11(4):e0153106. doi: 10.1371/journal.pone.0153106. eCollection 2016.

10.

Hepatitis C and hepatitis B-related mortality in Spain.

García-Fulgueiras A, García-Pina R, Morant C, García-Ortuzar V, Génova R, Alvarez E.

Eur J Gastroenterol Hepatol. 2009 Aug;21(8):895-901. doi: 10.1097/MEG.0b013e328313139d. Review.

PMID:
19357523
11.

Disease burden of foodborne pathogens in the Netherlands, 2009.

Havelaar AH, Haagsma JA, Mangen MJ, Kemmeren JM, Verhoef LP, Vijgen SM, Wilson M, Friesema IH, Kortbeek LM, van Duynhoven YT, van Pelt W.

Int J Food Microbiol. 2012 Jun 1;156(3):231-8. doi: 10.1016/j.ijfoodmicro.2012.03.029. Epub 2012 Apr 5.

PMID:
22541392
12.

Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.

Cassini A, Colzani E, Pini A, Mangen MJ, Plass D, McDonald SA, Maringhini G, van Lier A, Haagsma JA, Havelaar AH, Kramarz P, Kretzschmar ME, On Behalf Of The BCoDE Consortium.

Euro Surveill. 2018 Apr;23(16). doi: 10.2807/1560-7917.ES.2018.23.16.17-00454.

13.

The burden of infectious diseases in Europe: a pilot study.

van Lier EA, Havelaar AH, Nanda A.

Euro Surveill. 2007 Dec 1;12(12):E3-4.

PMID:
18076860
14.

[Infectious diseases in Poland in 2009].

Zieliński A, Czarkowski MP.

Przegl Epidemiol. 2011;65(2):171-9. Polish.

PMID:
21913454
15.

Disability-Adjusted Life Years for Communicable Disease in the Korean Burden of Disease Study 2012.

Lee YR, Moon K, Kim YA, Park SY, Oh CM, Lee KS, Oh IH.

J Korean Med Sci. 2016 Nov;31 Suppl 2:S178-S183. doi: 10.3346/jkms.2016.31.S2.S178.

16.

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

McMahon BJ, Holck P, Bulkow L, Snowball M.

Ann Intern Med. 2001 Nov 6;135(9):759-68.

PMID:
11694101
17.

Communicable Diseases Report, NSW, January and February 2010.

Communicable Diseases Branch; NSW Department of Health.

N S W Public Health Bull. 2010 Mar-Apr;21(3-4):103-7. doi: 10.1071/NB10025. No abstract available.

18.

[Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].

Liang S, Zhang SX, Ma QS, Xiao HW, Lü QY, Xie X, Mei SJ, Hu DS, Zhou BP, Li B, Chen JF, Cui FQ, Wang FZ, Liang XF.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1340-5. Chinese.

PMID:
21223660
19.

Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.

Thein HH, Walter SR, Gidding HF, Amin J, Law MG, George J, Dore GJ.

J Viral Hepat. 2011 Jul;18(7):e232-41. doi: 10.1111/j.1365-2893.2011.01440.x. Epub 2011 Feb 17.

PMID:
21692938
20.

The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.

Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, Scolastico C, Onofrio M, Imparato M, Filippini P.

J Med Virol. 2005 Apr;75(4):522-7.

PMID:
15714480

Supplemental Content

Support Center